Published in Hospital and Nursing Home Week, February 15th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Correlagen Diagnostics.
Report 1: Correlagen Diagnostics, Inc., a developer of molecular diagnostics, announced the availability of a test to detect genetically caused high cholesterol that may increase the risk of heart attacks.
Six hundred thousand Americans have a genetic cause of high cholesterol that increases their risk of suffering heart attacks at a very young age up to 125 fold. With proper diagnosis and treatment, using a combination of targeted...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week